{"transactions":[{"id":2317646,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-25T23:00:42.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on March 23, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.05,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001062993-22-008679","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299322008679/form4.xml","form_type":"4"}},{"id":2542336,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-15T01:46:17.000Z","date":"2021-10-13","kind":"purchase","acquired":true,"shares":5000,"price":12,"value":60000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001104659-21-126361","document":"tm2130061-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465921126361/tm2130061-2_4seq1.xml","form_type":"4"}},{"id":2544450,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-13T00:40:10.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":54457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares of common stock underlying the option vest on the first anniversary of the closing of the issuer's initial public offering. The remaining shares underlying the option vest in equal monthly installments thereafter for thirty-six (36) months, on the last day of each such month."}],"balance_after":54457,"derivative":{"exercise_price":12,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":54457},"source":{"system":"sec-edgar","filing":"0001882178-21-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000188217821000027/edgar.xml","form_type":"4"}},{"id":3706393,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2019-01-04T17:02:25.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted 52,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, beginning January 4, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include 10,500 Restricted Stock Units granted to the Reporting Person on January 3, 2019, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on January 3, 2022, and (ii) the continued service of the Reporting Person through January 3, 2022."}],"balance_after":33666,"derivative":{"exercise_price":2.8,"exercise_date":"2020-01-04","expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0000930413-19-000024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041319000024/ownership.xml","form_type":"4"}},{"id":3855968,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2018-08-02T19:06:34.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted 35,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, beginning August 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include 4,000 Performance Stock Units granted to the Reporting Person on July 31, 2018, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on July 31, 2021, and (ii) the continued service of the Reporting Person through July 31, 2021."}],"balance_after":23666,"derivative":{"exercise_price":4.42,"exercise_date":"2019-08-01","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000930413-18-002502","document":"c91792_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041318002502/c91792_4.xml","form_type":"4"}},{"id":4179002,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"exercise","acquired":false,"shares":8667,"price":4.35,"value":37701.45,"ownership":{"direct":true},"balance_after":52334,"derivative":{"exercise_price":4.35,"exercise_date":"2017-03-15","expiration_date":"2021-03-15","underlying":"Common Stock","underlying_shares":8667},"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4179001,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"exercise","acquired":false,"shares":7500,"price":3.4,"value":25500.0,"ownership":{"direct":true},"balance_after":61001,"derivative":{"exercise_price":3.4,"exercise_date":"2016-01-22","expiration_date":"2020-01-21","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4179000,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"exercise","acquired":false,"shares":6699,"price":2.75,"value":18422.25,"ownership":{"direct":true},"balance_after":68501,"derivative":{"exercise_price":2.75,"exercise_date":"2015-02-04","expiration_date":"2019-02-03","underlying":"Common Stock","underlying_shares":6699},"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4178999,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"sale","acquired":false,"shares":8667,"price":10.28,"value":89096.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.20 to $10.40, inclusive. The reporting person undertakes to provide to the Issuer, any\nsecurity holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":28187,"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4178998,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"sale","acquired":false,"shares":7500,"price":10.28,"value":77100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.20 to $10.40, inclusive. The reporting person undertakes to provide to the Issuer, any\nsecurity holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":36854,"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4178997,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"sale","acquired":false,"shares":6699,"price":10.28,"value":68865.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.20 to $10.40, inclusive. The reporting person undertakes to provide to the Issuer, any\nsecurity holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":44354,"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4178996,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"exercise","acquired":true,"shares":8667,"price":4.35,"value":37701.45,"ownership":{"direct":true},"balance_after":51053,"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4178995,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"exercise","acquired":true,"shares":7500,"price":3.4,"value":25500.0,"ownership":{"direct":true},"balance_after":42386,"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4178994,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-10-30T21:18:19.000Z","date":"2017-10-27","kind":"exercise","acquired":true,"shares":6699,"price":2.75,"value":18422.25,"ownership":{"direct":true},"balance_after":34886,"source":{"system":"sec-edgar","filing":"0000930413-17-003670","document":"c89632_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/316253/000093041317003670/c89632_4.xml","form_type":"4"}},{"id":4281673,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2017-06-15T17:10:44.000Z","date":"2017-06-13","kind":"exercise","acquired":false,"shares":2500,"price":3.4,"value":8500.0,"ownership":{"direct":true},"balance_after":75200,"derivative":{"exercise_price":3.4,"exercise_date":"2016-01-22","expiration_date":"2020-01-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001144204-17-032755","document":"v469092_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/316253/000114420417032755/v469092_4.xml","form_type":"4"}},{"id":4281672,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2017-06-15T17:10:44.000Z","date":"2017-06-13","kind":"exercise","acquired":false,"shares":13300,"price":2.75,"value":36575.0,"ownership":{"direct":true},"balance_after":77700,"derivative":{"exercise_price":2.75,"exercise_date":"2017-02-02","expiration_date":"2019-02-02","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001144204-17-032755","document":"v469092_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/316253/000114420417032755/v469092_4.xml","form_type":"4"}},{"id":4281671,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-06-15T17:10:44.000Z","date":"2017-06-13","kind":"sale","acquired":false,"shares":2500,"price":10.13,"value":25325.0,"ownership":{"direct":true},"balance_after":15800,"source":{"system":"sec-edgar","filing":"0001144204-17-032755","document":"v469092_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/316253/000114420417032755/v469092_4.xml","form_type":"4"}},{"id":4281670,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2017-06-15T17:10:44.000Z","date":"2017-06-13","kind":"sale","acquired":false,"shares":13300,"price":10.13,"value":134729.0,"ownership":{"direct":true},"balance_after":13300,"source":{"system":"sec-edgar","filing":"0001144204-17-032755","document":"v469092_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/316253/000114420417032755/v469092_4.xml","form_type":"4"}},{"id":4494479,"issuer":{"id":76314,"kind":"organization","name":"ENZO BIOCHEM INC","symbol":"ENZB"},"owners":[{"id":128776,"kind":"person","name":"O'Brien James Michael","position":1,"cik":"0001632111","reported_name":"O'Brien James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (to acquire common stock)","published_at":"2017-01-10T16:55:58.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted 30,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, begininning January 6, 2018."}],"balance_after":91000,"derivative":{"exercise_price":7.07,"exercise_date":"2018-01-06","expiration_date":"2022-01-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000914760-17-000008","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/316253/000091476017000008/formfour.xml","form_type":"4"}}]}